Top Banner
1 SCBM342-Cardiovascular Pathology Associate Professor Dr. Wannee Jiraungkoorskul Department of Pathobiology, Faculty of Science, Mahidol University Tel: 02-201-5563, E-mail: [email protected]
88

The Impact of Nanoparticles on Cellular Functions

Jan 11, 2022

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: The Impact of Nanoparticles on Cellular Functions

1

SCBM342-Cardiovascular Pathology

Associate Professor Dr. Wannee Jiraungkoorskul

Department of Pathobiology, Faculty of Science, Mahidol University

Tel: 02-201-5563, E-mail: [email protected]

Page 2: The Impact of Nanoparticles on Cellular Functions

2

• Mr. A is 55 years old, high 158 cm and weight 82 kg. He

works as the personal officer more than 30 years, smokes

cigarette 1 pack/day and drinks 2-3 times/week. What are

the risk factors of his disease or illness?

Problem

Page 3: The Impact of Nanoparticles on Cellular Functions

3

Cardiovascular Pathology

• Cardiac Failure

• Cardiac Adaptation

• Myocardial Infarction

• Endocarditis

• Myocarditis

• Pericarditis

• Cardiac tumor

Page 4: The Impact of Nanoparticles on Cellular Functions

4

• Heart failure is a clinical syndrome not a disease.

• The heart is unable to pump sufficient blood to the body

tissues to meet ordinary metabolic demands.

• HF is defined as “a complex clinical syndrome that an result

from any structural of functional cardiac disorder that

impairs the ability of the ventricle to eject blood (systolic

heart failure) or to fill with blood (diastolic heart failure) .”

(American Heart Association Guidelines 2013)

CARDIAC FAILURE: Definition

Page 5: The Impact of Nanoparticles on Cellular Functions

5

• Ischemic heart disease ~ 40 percent

• Dilated cardiomyopathy ~ 30 percent

• Primary valvular heart disease ~ 15 percent

• Hypertensive heart disease ~ 10 percent

• Other ~ 5 percent

CARDIAC FAILURE: Causes

Page 6: The Impact of Nanoparticles on Cellular Functions

6http://saypeople.com/wp-content/uploads/2011/05/Heart-failure-Symptoms.gif

Clinical Manifestations of CHF

Page 7: The Impact of Nanoparticles on Cellular Functions

7http://image.slidesharecdn.com/chf-140124151550-phpapp02/95/congestive-heart-failure-6-638.jpg?cb=1390576817

Page 8: The Impact of Nanoparticles on Cellular Functions

8

• Left heart failure

• Increase diastolic volume causes

– pulmonary congestion, edema, hemoptysis

• Decreased output causes

– renal ischemia, acute tubular necrosis, oliguria

– CNS ischemia, confusion

– bowel ischemia, GI bleeding, sepsis

– skeletal muscle ischemia, weakness, fatigue

CARDIAC FAILURE

Page 9: The Impact of Nanoparticles on Cellular Functions

9

Pulmonary edema and congestion

Page 10: The Impact of Nanoparticles on Cellular Functions

10

Pulmonary edema and congestion

Page 11: The Impact of Nanoparticles on Cellular Functions

11

Heart failure cells (Hemosiderin-laden macrophages)

Page 12: The Impact of Nanoparticles on Cellular Functions

12

“Heart failure cells” in lung

Page 13: The Impact of Nanoparticles on Cellular Functions

13

• Right heart failure

• Increase diastolic volume causes

– visceral congestion, edema and effusions

– pitting edema

• Usually caused by left heart failure

CARDIAC FAILURE

Page 14: The Impact of Nanoparticles on Cellular Functions

14

Page 15: The Impact of Nanoparticles on Cellular Functions

15

Nutmeg (ลกูจันทนเ์ทศ)Liver (passive congestion)

Myristica fragans

Page 16: The Impact of Nanoparticles on Cellular Functions

16

Liver, passive congestion

Page 17: The Impact of Nanoparticles on Cellular Functions

17

Pitting edema of leg in right heart failure

Page 18: The Impact of Nanoparticles on Cellular Functions

18

• What is not one of the main symptoms of heart failure?

A. Edema

B. Cool hands

C. Reduced urinary output

D. Shortness of breath

E. Stomach pain

Page 19: The Impact of Nanoparticles on Cellular Functions

19

• What is not a primary cause of heart failure?

A. Cardiomyopathy

B. Coronary artery disease

C. High blood pressure

D. Valvular disease

E. Polio

Page 20: The Impact of Nanoparticles on Cellular Functions

20

• What is the name for shortness of breath when lying

down?

A. Apnea

B. Orthopnea

C. Narcolepsy

D. Paroxysmal nocturnal dyspnea

E. Sleep apnea

Page 21: The Impact of Nanoparticles on Cellular Functions

21

• Right heart failure causes each of the following except:

A. Splenomegaly

B. Pulmonary edema

C. Ankle edema

D.Distended neck veins

E. Liver congestion

Page 22: The Impact of Nanoparticles on Cellular Functions

22

CARDIAC ADAPTATION

• CO = HR x SV (Male 5.6 L/min, Female 4.9 L/min)

• HR 60-180 beats per minute, SV 70-120 ml

Major cardiac adaptive changes to increased workload

• 1. Heart rate increases

• 2. Stroke volume increases

• 3. Hypertrophy

Page 23: The Impact of Nanoparticles on Cellular Functions

23

Page 24: The Impact of Nanoparticles on Cellular Functions

24

Page 25: The Impact of Nanoparticles on Cellular Functions

2525

Page 26: The Impact of Nanoparticles on Cellular Functions

2626

Page 27: The Impact of Nanoparticles on Cellular Functions

27

• Each of the following result in left ventricular hypertrophy

except:

A. Aortic stenosis

B. Coarctation of the aorta

C. Mitral stenosis

D.Severe prolonged anemia

E. Systemic hypertension

Page 28: The Impact of Nanoparticles on Cellular Functions

28

MYOCARDIAL INFARCTION

Etiology and pathogenesis

- Atherosclerosis of coronary arteries

- Decreased supply (atherosclerotic stenosis, coronary

thrombosis, vasospasm)

- Increased O2 demand (e.g., LVH due to hypertension or

aortic stenosis)

- Decreased pO2 with fixed stenosis (e.g., pulmonary

disease, anemia, high altitude, CO poisoning)

- M : F = 2-6 : 1

Page 29: The Impact of Nanoparticles on Cellular Functions

29

Page 30: The Impact of Nanoparticles on Cellular Functions

3030

Page 31: The Impact of Nanoparticles on Cellular Functions

31

48-hour-myocardial infarct

4 to 7 days MI

2 months MI

MYOCARDIAL INFARCTION

Page 32: The Impact of Nanoparticles on Cellular Functions

32

Page 33: The Impact of Nanoparticles on Cellular Functions

33

Page 34: The Impact of Nanoparticles on Cellular Functions

34

One-day-old infarct 3 to 4 days' duration

7 to 10 days’ duration Granulation tissues

Page 35: The Impact of Nanoparticles on Cellular Functions

35Well-healed myocardial infarct

Page 36: The Impact of Nanoparticles on Cellular Functions

36

Atherosclerotic plaque rupture.

A, Plaque rupture without superimposed thrombus, in patient who died suddenly.

B, Acute coronary thrombosis superimposed on an atherosclerotic plaque with focal disruption of the fibrous cap, triggering fatal myocardial infarction.

C, Massive plaque rupture with superimposed thrombus, also triggering a fatal myocardial infarction (special stain highlighting fibrin in red).

In both A and B, an arrow points to the site of plaque rupture.

Page 37: The Impact of Nanoparticles on Cellular Functions

37

Schematic representation of

sequential progression of

coronary artery lesion

morphology, beginning with

stable chronic plaque

responsible for typical

angina and leading to the

various acute coronary

syndromes.

Page 38: The Impact of Nanoparticles on Cellular Functions

38

Page 39: The Impact of Nanoparticles on Cellular Functions

39

Page 40: The Impact of Nanoparticles on Cellular Functions

40

Page 41: The Impact of Nanoparticles on Cellular Functions

41

Page 42: The Impact of Nanoparticles on Cellular Functions

42

Page 43: The Impact of Nanoparticles on Cellular Functions

43

Page 44: The Impact of Nanoparticles on Cellular Functions

44

Page 45: The Impact of Nanoparticles on Cellular Functions

45

Page 46: The Impact of Nanoparticles on Cellular Functions

46

Acute myocardial infarct, predominantly of the posterolateral left ventricle,

demonstrated histochemically by a lack of staining by the

triphenyltetrazolium chloride (TTC) stain in areas of necrosis (arrow). The

staining defect is due to the enzyme leakage that follows cell death. Note

the myocardial hemorrhage at one edge of the infarct that was associated

with cardiac rupture, and the anterior scar (arrowhead), indicative of old

infarct. (Specimen the oriented with the posterior wall at the top.)

Page 47: The Impact of Nanoparticles on Cellular Functions

47

• What term refers to damage of the heart muscle due to

inadequate blood flow?

A. Non-ischemic cardiomyopathy

B. Dilated cardiomyopathy

C. Hypertrophic cardiomyopathy

D. Ischemic cardiomyopathy

E. Cardioplegia

Page 48: The Impact of Nanoparticles on Cellular Functions

48

• Myocardial infarction or heart attack occurs when there is

blood clotting in_____.

A. Aorta

B. Coronary artery

C. Hepatic artery

D.Mesenteric artery

E. Renal artery

Page 49: The Impact of Nanoparticles on Cellular Functions

49

I. Types of endocarditis

– Non-infective

• acute rheumatic fever

• systemic lupus

• Non-bacterial thrombotic

– Infective

• Mainly bacterial or fungal infections

• Destroy valve tissue (non-infective doesn't)

• Thrombus with microorganisms

ENDOCARDITIS

Page 50: The Impact of Nanoparticles on Cellular Functions

50

Page 51: The Impact of Nanoparticles on Cellular Functions

51

• Inflammation

– Resulting in injury to cardiac myocyte

– Cardiac allograft rejection

– Collagen vascular disease

– Drug hypersensitivity

• Infection

– Virus

• Coxsackievirus A & B and other enterovirus (most common)

• Cytomegalovirus

• Human immunodeficiency virus

MYOCARDITIS

Page 52: The Impact of Nanoparticles on Cellular Functions

52

– Parasites

• Chagas’ disease (Trypanosoma cruzi)

(most common cause in S. America)

• Toxoplasmosis

– Bacteria

• Lyme disease

• Diphtheria (injury from toxin of Corynebacterium

diphtheriae)

MYOCARDITIS

Page 53: The Impact of Nanoparticles on Cellular Functions

53

• Morphology (Gross)

– Cardiac dilation

– Myocardium flabby,

pale, with

hemorrhage

MYOCARDITIS

Page 54: The Impact of Nanoparticles on Cellular Functions

54

Morphology (Microscopic):-

Acute virus infection

• Edema

• Inflammatory infiltrate of lymphocyte and other

mononuclear cell

• Myocyte degeneration and/or necrosis

• Viral inclusion may be present

MYOCARDITIS

Page 55: The Impact of Nanoparticles on Cellular Functions

55

Page 56: The Impact of Nanoparticles on Cellular Functions

56

Inflammation of the pericardium

Types and (in parentheses: causes)

- Fibrinous (MI, uremia)

- Purulent (Staphylococcus)

- Granulomatous (TB)

- Hemorrhagic (tumor, TB, uremia)

- Fibrous (constrictive)

PERICARDITIS

Page 57: The Impact of Nanoparticles on Cellular Functions

57

• Causes

– Infection

• virus (most common)

• pyogenic bacteria

• mycobacteria

• fungi

– Secondary

• acute myocardial infarction

• cardiac surgery

• radiation to mediastinum

PERICARDITIS

• Causes

– Systemic disorder

• uremia

• acute rheumatic fever

• systemic lupus

erythematosus

• metastatic malignancy

Page 58: The Impact of Nanoparticles on Cellular Functions

58

Page 59: The Impact of Nanoparticles on Cellular Functions

59

Page 60: The Impact of Nanoparticles on Cellular Functions

60

I. Most common are metastatic: lung, breast, melanoma

II. Primary tumor

Rare, but most common is left atrial myxoma

- arise from interatrial septum, on a stalk , mostly in LA

- can prolapse through MV into LV, cause CHF

- can embolize, cause stroke, etc.

CARDIAC TUMOR

Page 61: The Impact of Nanoparticles on Cellular Functions

61

MYXOMA

Pedunculated mass is

attached to the left arterial

endocardium.

(left -external surface, right

- cut surface)

Vascular showing basophilic myxoid stroma and stellate cells

Page 62: The Impact of Nanoparticles on Cellular Functions

62

Atrial myxoma

Minimal cellularity, only scattered spindle cells with scant pink cytoplasm are present in a loose myxoid stroma.

Page 63: The Impact of Nanoparticles on Cellular Functions

63

METASTATIC TUMOR

• Metastatic cardiac

tumors are 20X more

common than primary

tumors arising in the

heart

• Commonly from lung,

breast, lymphoma.

Page 64: The Impact of Nanoparticles on Cellular Functions

64

• What is the most common tumor of cardiac?

A. Cardiac squamous cell carcinoma

B. Cardiac metastasis

C. Cardiac adenocarcinoma

D.Cardiac small cell cancer

E. Cardiac large cell cancer

Page 65: The Impact of Nanoparticles on Cellular Functions

65

• What is the most common primary originating site of

cardiac metastases?

A. Breast cancer

B. Pancreas cancer

C. Testes cancer

D.Uterus cancer

E. Stomach cancer

Page 66: The Impact of Nanoparticles on Cellular Functions

66

• Atrial myxoma commonly arises from____.

A. Left atrium

B. Left ventricle

C. Right atrium

D.Right ventricle

E. Heart wall

Page 67: The Impact of Nanoparticles on Cellular Functions

67

• Narrowing or completely obstructing the lumina

– Atherosclerosis (thrombosis, embolism)

• Weakening of the wall.

– Dilatation or rupture

DISEASES OF ARTERIES

Page 68: The Impact of Nanoparticles on Cellular Functions

68

Degenerative arterial disease, segmental and

multifocal

• Characterized by intimal deposition of lipids,

which results in intimal thickening (atheroma)

and scarring

• Causes stenosis, predisposes to thrombosis

• Results in ischemia and infarction

ATHEROSCLEROSIS

Page 69: The Impact of Nanoparticles on Cellular Functions

69

Three types of lesions

• 1. Atheroma (raised, lipid center, dangerous)

• 2. Fatty streak (small, intracellular fat, innocuous)

• 3. Fibrous plaque (intimal scar, innocuous)

ATHEROSCLEROSIS

Page 70: The Impact of Nanoparticles on Cellular Functions

70

ATHEROMA LESION

Sites:

-Intimal, may involve media

- Aorta and its major branches

(coronaries, cerebrals,

peripheral, etc.)

Page 71: The Impact of Nanoparticles on Cellular Functions

71

ATHEROMA LESION

• Three major elements

– Necrotic center of extracellular lipid

– Fibrous cap

– Proliferating cells (myofibroblasts)

Page 72: The Impact of Nanoparticles on Cellular Functions

72

Mechanism for intimal thickening

Page 73: The Impact of Nanoparticles on Cellular Functions

73

Major components of well-developed atheromatous plaque

Page 74: The Impact of Nanoparticles on Cellular Functions

74

Schematic diagram of sequence of cellular events and cellular interaction in atherosclerosis

Page 75: The Impact of Nanoparticles on Cellular Functions

75

Summary of the pathology, pathogenesis, complications and natural history of atherosclerosis

Page 76: The Impact of Nanoparticles on Cellular Functions

76

Mild Severe

Fibrous plaque

Atherosclerosis, aorta

Page 77: The Impact of Nanoparticles on Cellular Functions

77

Page 78: The Impact of Nanoparticles on Cellular Functions

78

Page 79: The Impact of Nanoparticles on Cellular Functions

79

Page 80: The Impact of Nanoparticles on Cellular Functions

80

Page 81: The Impact of Nanoparticles on Cellular Functions

81

Page 82: The Impact of Nanoparticles on Cellular Functions

82

Page 83: The Impact of Nanoparticles on Cellular Functions

83

Atherosclerotic plaque with needles and clot

Page 84: The Impact of Nanoparticles on Cellular Functions

84

RISK FACTORS FOR ATHEROSCLEROSIS

Page 85: The Impact of Nanoparticles on Cellular Functions

85

Sites of atherosclerosis

Page 86: The Impact of Nanoparticles on Cellular Functions

86

Complication of

atherosclerosis

Page 87: The Impact of Nanoparticles on Cellular Functions

87

References

Illustrated Textbook

of Cardiovascular

Pathology.

by

P. Chopra

R. Ray

A. Saxena

2004

Practical

Cardiovascular

Pathology.

by

Allen Burke

Fabio Tavora

2010

Braunwald's Heart

Disease. 10th ed. by

Douglas Mann

Douglas Zipes

Peter Libby

Robert Bonow

2014

Practical

Cardiovascular

Pathology.

2nd ed. By

Mary Sheppard

2011

Page 88: The Impact of Nanoparticles on Cellular Functions

88

SCBM342

Cardiovascular Pathology